SINOCARE INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 26.65 CNY | -0.67% |
|
+0.30% | -12.34% |
| Jun. 07 | Sinocare Inc. Announces Dividend Implementation for 2023, Payable on 17 June 2024 | CI |
| May. 22 | Sinocare Inc. Approves Cash Dividend for the Year 2023 | CI |
| Sales 2024 * | 4.62B 636M | Sales 2025 * | 5.37B 740M | Capitalization | 14.76B 2.03B |
|---|---|---|---|---|---|
| Net income 2024 * | 433M 59.68M | Net income 2025 * | 560M 77.19M | EV / Sales 2024 * | 3.2 x |
| Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 2.75 x |
| P/E ratio 2024 * |
34.6
x | P/E ratio 2025 * |
26.9
x | Employees | 4,531 |
| Yield 2024 * |
1.03% | Yield 2025 * |
1.19% | Free-Float | 49.3% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.67% | ||
| 1 week | +0.30% | ||
| Current month | -4.38% | ||
| 1 month | +10.58% | ||
| 3 months | +19.40% | ||
| 6 months | -17.36% | ||
| Current year | -12.34% |
1 week
26.33
27.48
1 month
23.2028.50
Current year
19.1930.40
1 year
19.1933.28
3 years
13.3039.21
5 years
9.9853.69
10 years
9.6253.69
| Managers | Title | Age | Since |
|---|---|---|---|
Shao Bo Li
CEO | Chief Executive Officer | 59 | 02-07-31 |
Bo Shen Ou Yang
CHM | Chairman | 46 | 09-07-31 |
Chun Geng Chen
BRD | Director/Board Member | 47 | 16-11-30 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Shao Bo Li
CEO | Chief Executive Officer | 59 | 02-07-31 |
Shi Min Wang
PRN | Corporate Officer/Principal | 57 | 07-12-31 |
Hong Yuan
BRD | Director/Board Member | 66 | 19-12-22 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 114 M€ | +4.32% | - | |
| 0.00% | 32 M€ | +3.87% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-06-14 | 26.65 | -0.67% | 2,068,016 |
| 24-06-13 | 26.83 | +0.68% | 2,423,695 |
| 24-06-12 | 26.65 | -1.84% | 2,153,300 |
| 24-06-11 | 27.15 | +2.18% | 2,709,000 |
| 24-06-07 | 26.57 | -1.04% | 3,233,249 |
End-of-day quote Shenzhen S.E., June 13, 2024
More quotes
Sinocare Inc. is a China-based company principally engaged in the research, development, production and distribution of blood sugar monitoring systems. The Company mainly provides micro blood instant blood sugar monitoring systems including blood sugar testing instruments and related blood sugar testing strips, as well as blood sugar testing systems and mobile blood sugar instruments, among others. The Company also provides diabetes management information systems. It distributes its products within domestic market and to overseas markets under the brand name of SANNUO.
Calendar
2024-08-15
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
26.65
CNY
Average target price
29.52
CNY
Spread / Average Target
+10.77%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -12.34% | 2.03B | |
| -5.81% | 180B | |
| -1.63% | 106B | |
| -4.14% | 67.55B | |
| +13.22% | 45.79B | |
| -6.56% | 46.11B | |
| +6.13% | 41.61B | |
| +19.93% | 31.07B | |
| +13.61% | 24.77B | |
| -5.36% | 24.27B |
- Stock Market
- Equities
- 300298 Stock
